New Guangdong Model Sets Dangerous Precedent For Next Round Of Drug Tenders
This article was originally published in PharmAsia News
Executive Summary
Guangdong province recently published new draft rules for drug tenders, getting a sharp response from domestic manufacturers that say the rules focus too much on price and not enough on quality.